PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1536718
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1536718
Centrifugation-free Sperm Separation System Market size was valued at USD 118.6 Million in 2023, expanding at a CAGR of 4.00% from 2024 to 2032.
The goal of a centrifugation-free sperm separation system is to preserve the DNA integrity and functional competence of specific spermatozoa while removing the hazards associated with centrifugation in the swim-up approach. It functions by utilizing a filter that is specifically made to let sperm cells flow through while keeping the other ingredients in the semen. After filtering, the sperm cells can be gathered, and their quality and quantity examined. The harm that centrifugation causes to sperm can be avoided with the aid of a sperm separation system that does not require centrifugation. The market is being driven by several factors, including the significant growth of the healthcare sector, increased awareness of the declining infertility rate, and intensive research and development (R&D) activities. In addition, the need for sperm separation methods without centrifugation is primarily being driven by the rise in in-vitro fertilization facilities worldwide. Approximately 456 in-vitro fertilization clinics provide infertility treatments in the United States, according to the Centers for Disease Control and Prevention.
Centrifugation-free Sperm Separation System Market- Market Dynamics
Rise in the Number of IVF Centers and Infertility Incidence in Men and Women
The rise in the prevalence of infertility in both men and women drives the need for sperm separation devices without centrifugation. The CDC estimates that 6% of married women in the United States between the ages of 15 and 44 have infertility or the inability to conceive after a year of trying. Furthermore, regardless of marital status, 12% of women in the nation between the ages of 15 and 44 experience impaired fecundity, which is the inability to become pregnant or carry a pregnancy to term. An estimated 48.5 million couples worldwide are affected by infertility or 15% of all couples. Males are shown to be the only factor in 20% to 30% of cases of infertility and to make up 50% of cases in total. Furthermore, the need for sperm separation methods without centrifugation is primarily being driven by the rise in in-vitro fertilization facilities worldwide. Approximately 456 in-vitro fertilization clinics provide infertility treatments in the United States, according to the Centers for Disease Control and Prevention.
Centrifugation-free Sperm Separation System Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.00% over the forecast period (2024-2032)
Based on type segmentation, the microfluidic sperm sorters (MFSSs) category was predicted to show maximum market share in the year 2023
Based on end-user segmentation, the hospitals and clinics category was the leading segment in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Centrifugation-free Sperm Separation System Market is segmented on the basis of Type, End-user, and Region.
The market is divided into the following categories based on type: Migration-Sedimentation (MS) and Microfluidic Sperm Sorters (MFSSs). The microfluidic sperm sorters (MFSSs) category dominates the market. Market expansion for centrifugation-free sperm separation systems is anticipated due to the quick development of non-centrifugation methods, especially those based on microfluidic technology. This expansion is anticipated to be fueled by the growing use of microfluidic sperm sorters, especially in clinical settings where their capacity to minimize DNA damage is highly appreciated. The ability of these methods to preserve the DNA integrity of particular spermatozoa is also well-known, as it reduces the possibility of radiation-induced DNA damage. Although the use of microfluidic technology in IUI and IVF procedures is just beginning to gain popularity, it has the potential to reduce the incidence of iatrogenic pregnancy failures in the long run.
The market is divided into the following categories based on end-user: Hospitals and Clinics, Cryobanks, IVF Centers, and Others. The hospitals and clinics category dominates the market and is likely to maintain its dominance during the forecast period. In vitro fertilization procedures are primarily carried out in hospitals. Government healthcare institutions claim that hospitals have sophisticated medical technology systems and reimbursement programs. The rise in the quantity of healthcare institutions worldwide is the reason for the segment's progress. The global expansion in surgical procedures and hospital infrastructure further propels the industry.
Centrifugation-free Sperm Separation System Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for centrifugation-free sperm separation systems. It is explained by the growing number of prominent figures in the sector, significant R&D efforts directed towards sperm-sorting apparatuses, and quick developments in microfluidics technology for sperm selection methods. The market in the area is growing and developing as a result of all these variables together.
In addition, the centrifugation-free sperm separation system market is anticipated to expand at the fastest rate in the world during the projected period in the Asia Pacific because there has been a discernible rise in cases of infertility in both genders in recent years. This increase is expected to support the regional market's expansion as centrifugation-free sperm-separating methods become more widely used in IVF clinics and centers. Moreover, over the analysis period, the rising need for cutting-edge sperm separation technologies is anticipated to fuel market expansion in the Asia Pacific.
The existence of numerous manufacturers has caused fragmentation in the global market for centrifugation-free sperm separation system. The following are some of the leading companies in the global centrifugation-free sperm separation system market: CooperSurgical Inc, Memphasys Ltd, DxNow, and SAR Healthline Pvt. Ltd. A variety of tactics, such as partnerships, joint ventures, license agreements, mergers and acquisitions, and the introduction of new products, are used by these companies to increase their market share.
January 2024: Memphasys, a business that specializes in cutting-edge sperm-separation technology, said that it has raised USD 4.23 million in funding to make the leap from research and development to commercialization.
GLOBAL CENTRIFUGATION-FREE SPERM SEPARATION SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
CooperSurgical Inc
Memphasys Ltd
DxNow
SAR Healthline Pvt. Ltd.
Koek Biotechnology Bioengineering and Medical Services Industry & Trade Inc
Lotus Bio.
Others